Clinical Trials · NCT01208649
Effects of Exenatide (Byetta®) on Liver Function in Patients With Nonalcoholic Steatohepatitis (NASH)
- Phase
- Phase 4
- Recruitment status
- Completed
- Sponsor
- Ruhr University of Bochum
- Enrollment
- 13
- Start date
- Jul 2008
- Locations
- 1 site, Germany
- Primary endpoint
- histological activity of NASH (steatosis, necroinflammation, ballooning)